Infraredx
11
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
27.3%
3 terminated/withdrawn out of 11 trials
72.7%
-13.8% vs industry average
18%
2 trials in Phase 3/4
63%
5 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon
Role: lead
Resveratrol Excipient Paclitaxel Coated Balloon for Coronary Treatment
Role: collaborator
PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial.
Role: collaborator
SPECTACL: SPECTroscopic Assessment of Coronary Lipid
Role: lead
In Vitro and In Vivo Comparison Between Intravascular Ultrasound (IVUS) Systems
Role: lead
The Lipid-Rich Plaque Study
Role: lead
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
Role: lead
An Observational Study of Cholesterol in Coronary Arteries
Role: lead
Intravascular Near Infrared Spectroscopy (NIRS) Bifurcation - Lipid Core Plaque Shift Study
Role: lead
Evaluation of a Combined Near Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) Catheter for Detection of Lipid Rich Plaque
Role: collaborator
Study of Near Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) Combination Coronary Catheter
Role: lead
All 11 trials loaded